Liposomal Bupivacaine Decreases Intravenous Opioid Use in Patients with Hip Fracture: A Modification to a Novel Pain Protocol.

Kimberly L StevensonMatthew K SteinGeorge W FryhoferSean LoobyDerek DoneganSamir Mehta

Published in: The Journal of the American Academy of Orthopaedic Surgeons (2023)

The inclusion of liposomal bupivacaine in our institution's novel pain protocol led to notable decreases in opioid requirement in all postoperative days studied with a trend toward decreased delirium rates as well.

Keyphrases

pain management
hip fracture
chronic pain
postoperative pain
randomized controlled trial
neuropathic pain
patients undergoing
high dose
spinal cord
solid state